Page last updated: 2024-10-30

methazolamide and Metabolic Diseases

methazolamide has been researched along with Metabolic Diseases in 1 studies

Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, Z1
Peng, M1
Chen, P1
Liu, C1
Hu, A1
Zhang, Y2
Peng, J1
Liu, J1
Li, Y1
Li, W1
Zhu, W1
Guan, D1
Chen, H1
Li, J1
Fan, D1
Huang, K1
Lin, F1
Zhang, Z1
Guo, Z1
Luo, H1
He, X1
Zhu, Y1
Li, L1
Huang, B1
Cai, W1
Gu, L1
Lu, Y1
Deng, K1
Yan, L1
Chen, S1

Other Studies

1 other study available for methazolamide and Metabolic Diseases

ArticleYear
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
    Cell metabolism, 2022, 03-01, Volume: 34, Issue:3

    Topics: Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chlorocebus aethiops; COVID-19; COVID-19

2022